An Extension to Assess the Effect of Expanded Dialysis on Patient Reported Symptoms Using LEVIL
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 100 participants.
Also called NCT06032208
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 100 participants
- Sponsor
- Registry
-
NCT06032208
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Canada
- Registry status
- Recruiting
Technical summary
Registry record NCT06032208. Allocation not applicable; no masking; primary purpose treatment. Start 2024-03-01 (actual); primary completion 2026-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- An Extension to Assess the Effect of Expanded Dialysis on Patient Reported Symptoms Using LEVIL
- Condition
- End Stage Renal Disease
- Intervention (Device)
- Theranova Dialyzer
- Lead sponsor
- London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- Collaborator
- Baxter Healthcare Corporation
Record details
- Record id
cardio:ct-nct06032208- Content hash
496b38a7225eb440eeae2f4034eda0cfcdd7f2059b006c91c59c738152a75be0